Jump to content
We need you! See something you could improve? Make an edit and help improve WikSM for everyone.

Avascular Necrosis Main

From WikiSM
(Redirected from Avascular Necrosis (Main))

Other Names

  • Osteonecrosis
  • AVN
  • Aseptic necrosis
  • Atraumatic necrosis
  • Ischemic necrosis

Background

  • This page is a home page for all causes of avascular necrosis (AVN), also often referred to as osteonecrosis

History

Epidemiology

  • Estimated 20,000 - 30,000 cases per year in the US[1]

Pathophysiology

  • General
    • Degenerative bone condition characterized by death of cellular components of bone secondary to interruption of subchondral blood supply[2]
    • Low blood supply leads to hypoxia, loss of integrity of cell membrane, necrosis of osteocytes
    • Histology marked by appearance of neutrophils, macrophages
    • Macroscopically, leads to subchondral collapse and joint degeneration
    • Most commonly affects the epiphysis of long bones of weight-bearing joints
  • Timeline & Disease progression
    • Often goes undiagnosed early in disease course due to most patients being asymptomatic early on
    • Important to recognize early to maximize best outcomes for patients
    • Can result in subchondral collapse, threatening integrity of joint

Etiology

  • General
    • Likely combination of genetic predisposition, metabolic factors and local factors affecting vascular supply

Glucocorticoids

  • General
    • Frequency and risk varies depending on duration of use, dose and comorbidities
    • One study estimated incidence between 21 and 37% after one year of glucocorticoid therapy[3]
    • Risk estimated to be less than 3% on low dose prednisone (less than 15-20 mg/day)
    • In patients on short-term, low dose methylprednisolone estimated incidence to be 0.13%[4], however the risk was as high as 1.6% compared to patients who did not receive any methylprednisolone
    • Higher doses early on seem to correlate with risk as well[5]
  • Proposed mechanisms
    • Alterations in circulating lipids, resultant microemboli[6]
    • Bone marrow adipocyte hypertrophy blocks venous outflow[7]
    • Changes in venous endothelial cells, leading to stasis, increased intraosseuous pressure, necrosis[8]

Alcohol

  • Alcohol use is seen in up to 31% of patients with AVN[9]
  • Risk is directly correlated with increased consumption

Systemic Lupus Erythematosus

  • Reported in between 3 and 30% of patients with SLE[10]
  • Generally associated with glucocorticoid use, although there are case reports in patients who haven't used glucocorticoids

Trauma

  • 80% are associated with either history of glucocorticoids or excessive alcohol use[11]
  • In hip dislocations, one study estimated the incidence of AVN to be 14.3%[12]
  • Risk also increased in scaphoid and lunate fractures

Transplant History

  • Renal Transplantation
    • Affects between 50 and 70% of patients
    • Incidence estimated to be 15% in first 3 years after transplant[13]
    • Use of cyclosporine appears to decrease risk
  • Hematopoeitic Cell Transplant
    • One study estimated the prevalence ranged ranged from 2% (autologous) to 10% (allogenic)[14]
    • May also dependent on sex of donor and recipient with female-to-female recipient having the highest risk[15]

Risk Factors


Regional AVNs


Clinical Features

  • History
    • Often asymptomatic early in course of disease
    • Generally atraumatic with insidious onset of pain
    • In the lower extremities, pain is worse with ambulation
  • Physical Exam
    • May be normal, see specific diseases

Evaluation

Radiographs

  • Screening of affected joint is initial imaging modality of choice
  • Early in disease course often will appear normal
  • As disease progresses, findings include:
    • Mild density changes (early)
    • Subchondral collapse
    • Sclerosis and cysts

MRI

  • Sensitivity up to 100%[20]
  • Findings:
    • Focal lesions (T1)
    • "double line sign" or high intensity line (T2) is pathognomonic

Bone Scintography

  • Falling out of use in favor of MRI which is more sensitive, specific[21]
  • Remains an option in patients who can not obtain an MRI

Classification

  • Needs to be updated

Management

* Variable, see individual diseases

Prognosis

  • Mont et al. reported that 59% of asymptomatic lesions progressed to symptoms or collapse[22]

Rehab and Return to Play

Rehabilitation

  • Variable, see individual diseases

Return to Play

  • Variable, see individual diseases

Complications

  • Inability to return to sport
  • Chronic pain

See Also


References


  1. Moya-Angeler, Joaquin, et al. "Current concepts on osteonecrosis of the femoral head." World journal of orthopedics 6.8 (2015): 590.
  2. 2.0 2.1 Shah KN, Racine J, Jones LC, Aaron RK. Pathophysiology and risk factors for osteonecrosis. Curr Rev Musculoskelet Med. 2015 Sep;8(3):201-9.
  3. Shigemura, Tomonori, et al. "Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study." Rheumatology 50.11 (2011): 2023-2028.
  4. Dilisio, Matthew F. "Osteonecrosis following short-term, low-dose oral corticosteroids: a population-based study of 24 million patients." Orthopedics 37.7 (2014): e631-e636.
  5. Abeles, Micha, Jeffery D. Urman, and Naomi F. Rothfield. "Aseptic necrosis of bone in systemic lupus erythematosus: relationship to corticosteroid therapy." Archives of Internal Medicine 138.5 (1978): 750-754.
  6. Jones Jr, J. P. "Fat embolism and osteonecrosis." The Orthopedic Clinics of North America 16.4 (1985): 595-633.
  7. SoLoMoN, L. O. U. I. S. "Idiopathic necrosis of the femoral head: pathogenesis and treatment." Canadian journal of surgery. Journal canadien de chirurgie 24.6 (1981): 573.
  8. Nishimura, Tatsuya, et al. "Histopathologic study of veins in steroid treated rabbits." Clinical orthopaedics and related research 334 (1997): 37-42.
  9. Matsuo, Keisuke, et al. "Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head." Clinical orthopaedics and related research 234 (1988): 115-123.
  10. Dimant, J., et al. "Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE." The Journal of rheumatology 5.2 (1978): 136-141.
  11. Mont, Michael A., and David S. Hungerford. "Non-traumatic avascular necrosis of the femoral head." JBJS 77.3 (1995): 459-474.
  12. Slobogean, G. P., et al. "Complications following young femoral neck fractures." Injury 46.3 (2015): 484-491.
  13. IBELS, LLOYD S., et al. "Aseptic necrosis of bone following renal transplantation: experience in 194 transplant recipients and review of the literature." Medicine 57.1 (1978): 25-46.
  14. Tauchmanovà, Libuse, et al. "Avascular necrosis in long‐term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review." Cancer: Interdisciplinary International Journal of the American Cancer Society 97.10 (2003): 2453-2461.
  15. Schulte, Claudia MS, and Dietrich W. Beelen. "Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter." Transplantation 78.7 (2004): 1055-1063.
  16. Gómez-Puerta, Jose A., et al. "High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature." Medicine 92.6 (2013): 295.
  17. Jones, Lynne C., et al. "Procoagulants and osteonecrosis." The Journal of rheumatology 30.4 (2003): 783-791.
  18. Miller, Kirk D., et al. "High prevalence of osteonecrosis of the femoral head in HIV-infected adults." Annals of internal medicine 137.1 (2002): 17-25.
  19. Liu, Yu-Fen, et al. "Type II collagen gene variants and inherited osteonecrosis of the femoral head." New England Journal of Medicine 352.22 (2005): 2294-2301.
  20. Markisz, John A., et al. "Segmental patterns of avascular necrosis of the femoral heads: early detection with MR imaging." Radiology 162.3 (1987): 717-720.
  21. Mont, Michael A., et al. "Bone scanning of limited value for diagnosis of symptomatic oligofocal and multifocal osteonecrosis." The Journal of rheumatology 35.8 (2008): 1629-1634.
  22. Mont MA, Zywiel MG, Marker DR, McGrath MS, Delanois RE. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am. 2010 Sep 15;92(12):2165-70.
Created by:
John Kiel on 30 June 2019 20:48:14
Authors:
Last edited:
31 May 2025 19:53:47
Categories: